Acton Senior Fellow Marvin Olasky in a column today on looks at the “important new coalition” called Kill Malarial Mosquitoes Now that is working to bring the banned pesticide DDT back into battle against malaria. The disease, he writes, kills an estimated 1 million people annually — 90 percent of them Africans.

The United States has been contributing about $200 million per year to Africa’s war on malaria. Four months ago, President Bush promised an additional $1.2 billion over five years in U.S. anti-malaria funding. But last week, a coalition of 100 doctors, scientists and activists said that anti-malaria funds up to now have been misspent.

The KMMN coalition — which includes eminent malaria experts and public health specialists, the former U.S. Navy surgeon general, the national chairman of the Congress of Racial Equality, a co-founder of Greenpeace, the president of the National Black Chamber of Commerce and the president of the Association of American Physicians and Surgeons — says most of the annual $200 million goes to advising African governments on how bat malaria, not on bat.

The KMMN coalition says that none of that money goes for the most effective weapon: the insecticide DDT, which eradicated malaria in Europe and the United States more than half a century ago, but was banned in the United States in 1972 because of its supposed environmental effects. Soon, the World Health Organization and the U.S. Agency for International Development cut out DDT from its programs.

Read the “Kill Malarial Mosquitoes Now!” declaration and add your name to the growing list of endorsers by emailing “info [at] acton [dot] org” with your name, degrees, and organizational affiliation. Acton will forward your name to the Africa Fighting Malaria advocacy group.

Steven Milloy, publisher of and an adjunct scholar at the Cato Institute, argues that “there is no economical substitute for DDT when es to malaria in poorer regions of the world.”

When DDT is available, the results are nothing short of spectacular. Indoor spraying with DDT, for example, reduced malaria cases and deaths by nearly 75 percent in Zambia over a two-year period and by 80 percent in South Africa in just one year. DDT works like nothing else – there’s simply no doubt about it.

For these reasons, we ought to support a bill in Congress (currently it’s known as the Senate version of H.R. 3057) that would reform the U.S. Agency for International Development so that insecticides like DDT could be added to the arsenal for fighting malaria. President Bush announced in July that U.S. taxpayers would spend $1.2 billion for world malaria control over the next five years.

Rather than wasting that money on ineffective bed nets and anti-malaria drugs – and then repeating such futility in another five years – let’s spend it on DDT and get the job done now.